Aimmune Therap (AIMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 2,269 | 11,951 |
| TOTAL | $2,375 | $12,071 |
| Non-Current Assets | ||
| PPE Net | 87 | 60 |
| Other Non-Current Assets | 69 | 25 |
| TOTAL | $156 | $85 |
| Total Assets | $2,531 | $12,156 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 478 | 272 |
| Accrued Expenses | 1,259 | 238 |
| Other current liabilities | 67 | 9 |
| TOTAL | $1,804 | $519 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 56 | 0 |
| TOTAL | $56 | $N/A |
| Total Liabilities | $1,860 | $519 |
| Shareholders' Equity | ||
| Retained earnings | -17,517 | -6,397 |
| Other shareholders' equity | 16,928 | 16,928 |
| TOTAL | $671 | $11,637 |
| Total Liabilities And Equity | $2,531 | $12,156 |